| Comprehensive genomic profiling identifies novel genetic predictors of response to anti–PD-(L) 1 therapies in non–small cell lung cancer W Fang, Y Ma, JC Yin, S Hong, H Zhou, A Wang, F Wang, H Bao, X Wu, ... Clinical Cancer Research 25 (16), 5015-5026, 2019 | 156 | 2019 |
| The genomic landscape of Epstein-Barr virus-associated pulmonary lymphoepithelioma-like carcinoma S Hong, D Liu, S Luo, W Fang, J Zhan, S Fu, Y Zhang, X Wu, H Zhou, ... Nature communications 10 (1), 3108, 2019 | 89 | 2019 |
| Education and lung cancer: a Mendelian randomization study H Zhou, Y Zhang, J Liu, Y Yang, W Fang, S Hong, G Chen, S Zhao, ... International journal of epidemiology 48 (3), 743-750, 2019 | 86 | 2019 |
| Nomogram to predict cause-specific mortality in patients with surgically resected stage I non–small-cell lung cancer: a competing risk analysis H Zhou, Y Zhang, Z Qiu, G Chen, S Hong, X Chen, Z Zhang, Y Huang, ... Clinical lung cancer 19 (2), e195-e203, 2018 | 68 | 2018 |
| Impact of prior cancer history on the overall survival of patients newly diagnosed with cancer: A pan‐cancer analysis of the SEER database H Zhou, Y Huang, Z Qiu, H Zhao, W Fang, Y Yang, Y Zhao, X Hou, Y Ma, ... International journal of cancer 143 (7), 1569-1577, 2018 | 64 | 2018 |
| The correlations of tumor mutational burden among single-region tissue, multi-region tissues and blood in non-small cell lung cancer Y Zhang, L Chang, Y Yang, W Fang, Y Guan, A Wu, S Hong, H Zhou, ... Journal for immunotherapy of cancer 7 (1), 98, 2019 | 63 | 2019 |
| Marital status is an independent prognostic factor for pancreatic neuroendocrine tumors patients: An analysis of the Surveillance, Epidemiology, and End Results (SEER) database H Zhou, Y Zhang, Y Song, W Tan, Z Qiu, S Li, Q Chen, S Gao Clinics and research in hepatology and gastroenterology 41 (4), 476-486, 2017 | 60 | 2017 |
| Which is the optimal immunotherapy for advanced squamous non-small-cell lung cancer in combination with chemotherapy: anti-PD-1 or anti-PD-L1? Y Zhang, H Zhou, L Zhang Journal for immunotherapy of cancer 6, 1-4, 2018 | 57 | 2018 |
| Intratumor heterogeneity comparison among different subtypes of non-small-cell lung cancer through multi-region tissue and matched ctDNA sequencing Y Zhang, L Chang, Y Yang, W Fang, Y Guan, A Wu, S Hong, H Zhou, ... Molecular cancer 18 (1), 7, 2019 | 56 | 2019 |
| Competing risk nomograms for nasopharyngeal carcinoma in the intensity-modulated radiotherapy era: a big-data, intelligence platform-based analysis XD Huang, GQ Zhou, JW Lv, HQ Zhou, CW Zhong, CF Wu, ZQ Zheng, ... Radiotherapy and Oncology 129 (2), 389-395, 2018 | 51 | 2018 |
| Reporting of immune checkpoint inhibitor therapy–associated diabetes, 2015–2019 J Liu, H Zhou, Y Zhang, W Fang, Y Yang, Y Huang, L Zhang Diabetes care 43 (7), e79, 2020 | 48 | 2020 |
| PBRM1 mutation and preliminary response to immune checkpoint blockade treatment in non-small cell lung cancer H Zhou, J Liu, Y Zhang, Y Huang, J Shen, Y Yang, W Fang, L Zhang NPJ precision oncology 4 (1), 6, 2020 | 47 | 2020 |
| A bibliometric analysis in gene research of myocardial infarction from 2001 to 2015 H Zhou, W Tan, Z Qiu, Y Song, S Gao PeerJ 6, e4354, 2018 | 45 | 2018 |
| Racial disparities in pancreatic neuroendocrine tumors survival: a SEER study H Zhou, Y Zhang, X Wei, K Yang, W Tan, Z Qiu, S Li, Q Chen, Y Song, ... Cancer medicine 6 (11), 2745-2756, 2017 | 43 | 2017 |
| Intratumoral heterogeneity as a predictive biomarker in anti-PD-(L) 1 therapies for non-small cell lung cancer W Fang, H Jin, H Zhou, S Hong, Y Ma, Y Zhang, X Su, L Chen, Y Yang, ... Molecular cancer 20 (1), 37, 2021 | 41 | 2021 |
| Applying deep learning in recognizing the femoral nerve block region on ultrasound images C Huang, Y Zhou, W Tan, Z Qiu, H Zhou, Y Song, Y Zhao, S Gao Annals of Translational Medicine 7 (18), 2019 | 38 | 2019 |
| Multi-region exome sequencing reveals the intratumoral heterogeneity of surgically resected small cell lung cancer H Zhou, Y Hu, R Luo, Y Zhao, H Pan, L Ji, T Zhou, L Zhang, H Long, J Fu, ... Nature communications 12 (1), 5431, 2021 | 34 | 2021 |
| Bioinformatic analysis of potential biomarkers for spinal cord–injured patients with intractable neuropathic pain Y Wang, F Ye, C Huang, F Xue, Y Li, S Gao, Z Qiu, S Li, Q Chen, H Zhou, ... The Clinical journal of pain 34 (9), 825-830, 2018 | 33 | 2018 |
| Multiple machine learnings revealed similar predictive accuracy for prognosis of PNETs from the surveillance, epidemiology, and end result database Y Song, S Gao, W Tan, Z Qiu, H Zhou, Y Zhao Journal of Cancer 9 (21), 3971, 2018 | 31 | 2018 |
| A modifiable risk factors atlas of lung cancer: A Mendelian randomization study J Shen, H Zhou, J Liu, Y Zhang, T Zhou, Y Yang, W Fang, Y Huang, ... Cancer medicine 10 (13), 4587-4603, 2021 | 30 | 2021 |
SHAODONG HONGSUN YAT-SEN UNIVERSITY CANCER CENTER在 sysucc.org.cn 的电子邮件经过验证
